ShareValue scores for 605199.SHG: Valuation 46, Quality 32, Growth 25, Health 33.

605199.SHG
SSE

Hainan Huluwa Pharmaceutical Group Co Ltd

CN¥6.03(+0.33%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

1% to 15%
Valuation
46
Fair Value
Price vs Value
Quality
32
Weak
Business Strength
Growth
25
Weak
Revenue & Earnings
Health
33
Stressed
Financial Stability
Momentum
22
Bearish
Price Trend

Company Details

About

Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other fields in China. The company offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. Hainan Huluwa Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Haikou, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026